Pharmacological Treatment of Schizophrenia:-Reference-Cited by-同舟云学术

Pharmacological Treatment of Schizophrenia:

Published:2016 Issue:0 Volume:7 Page:1-8
ISSN:1884-8826
Container-title:Clinical Neuropsychopharmacology and Therapeutics
language:en
Short-container-title:CNPT

Author:

Fleischhacker W. Wolfgang¹,Miyamoto Seiya²

Affiliation:

1. Department of Psychiatry, Psychotherapy and Psychosomatics, Medical University Innsbruck

2. Department of Neuropsychiatry, St. Marianna University School of Medicine

Publisher

The Japanese Society of Clinical Neuropsychopharmacology

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology

Link

https://www.jstage.jst.go.jp/article/cnpt/7/0/7_1/_pdf

Reference62 articles.

1. [1] Miyamoto S, Fleischhacker WW, Lieberman JA. Pharmacologic treatment of schizophrenia. In: Lieberman JA, Murray R, editors. Comprehensive Care of Schizophrenia (Second Edition): A Textbook of Clinical Management. New York: Oxford University Press; 2012. p. 77-138.

2. [2] Liu CC, Demjaha A. Antipsychotic interventions in prodromal psychosis: safety issues. CNS Drugs. 2013;27:197-205.

3. [3] Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA psychiatry. 2013;70:107-120.

4. [4] Correll CU, Hauser M, Auther AM, Cornblatt BA. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry. 2010;51:390-431.

5. [5] Miller TJ, McGlashan TH, Rosen JL, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863-865.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database;Frontiers in Psychiatry;2023-04-06

2. Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence;CNS Neuroscience & Therapeutics;2021-02-08

3. Relationship of Long Acting Injectable Antipsychotics with Caregiver Burden, Quality of Life, Symptom Severity and Treatment Discontinuation in Schizophrenia;Turkish Journal of Psychiatry;2021

4. Functional impairment of cortical AMPA receptors in schizophrenia;Schizophrenia Research;2020-06

5. Olanzapine Pamoate Use for Schizophrenia: Retrospective Records Based Study from a Tertiary Care Hospital;Indian Journal of Psychological Medicine;2020-03